Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Oshimi

Showing results (41-50 of 206) with videos related to

Pageof 21
Sort By:
Journal of Clinical Immunology|July 1, 1981
Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumorsH Wakasugi, K Oshimi, M Miyata, et al.
Blood|December 15, 1991
Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disordersS Hoshino, K Oshimi, M Teramura, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1983
Enhancement of human leukemic colony formation by mature granulocytes and autologous leukemic cellsT Motoji, H Mizoguchi, K Oshimi, et al.
Stem Cells (Dayton, Ohio)|August 26, 1998
Direct measurement of CD34+ blood stem cell absolute counts by flow cytometryJ Fukuda, T Kaneko, M Egashira, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1984
[A case of pure red cell aplasia developing during the course of myelodysplastic syndrome and successfully treated with immunosuppressive agents]M Takahashi, M Akahoshi, K Oshimi, et al.
Journal of the National Cancer Institute|December 1, 1980
Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432K Oshimi, S Kano, F Takaku, et al.
British Journal of Cancer|May 1, 1982
Proliferative state and radiosensitivity of human myeloma stem cellsT Shimizu, T Motoji, K Oshimi, et al.
Cellular Immunology|December 1, 1988
Characterization of interleukin 2-expanded human peripheral blood lymphocytes: not only NKH-1+-NK cells but also NKH-1+ and NKH-1- T cells are LAK effectorsH Saito, K Oshimi, Y Oshimi, et al.
Immunology|March 1, 1992
Induction of activated killer cells from human lymphocytes by medullasin (a serine protease in bone marrow cells)Y Aoki, T Hase, K Oshimi, et al.
Leukemia & Lymphoma|September 1, 1994
Interleukin-11S Kobayashi, M Teramura, K Oshimi, et al.
Pageof 21

Showing results (41-50 of 206) with videos related to

Sort By:
Pageof 21
Journal of Clinical Immunology|July 1, 1981
Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumorsH Wakasugi, K Oshimi, M Miyata, et al.
Blood|December 15, 1991
Activation via the CD3 and CD16 pathway mediates interleukin-2-dependent autocrine proliferation of granular lymphocytes in patients with granular lymphocyte proliferative disordersS Hoshino, K Oshimi, M Teramura, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|December 1, 1983
Enhancement of human leukemic colony formation by mature granulocytes and autologous leukemic cellsT Motoji, H Mizoguchi, K Oshimi, et al.
Stem Cells (Dayton, Ohio)|August 26, 1998
Direct measurement of CD34+ blood stem cell absolute counts by flow cytometryJ Fukuda, T Kaneko, M Egashira, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1984
[A case of pure red cell aplasia developing during the course of myelodysplastic syndrome and successfully treated with immunosuppressive agents]M Takahashi, M Akahoshi, K Oshimi, et al.
Journal of the National Cancer Institute|December 1, 1980
Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432K Oshimi, S Kano, F Takaku, et al.
British Journal of Cancer|May 1, 1982
Proliferative state and radiosensitivity of human myeloma stem cellsT Shimizu, T Motoji, K Oshimi, et al.
Cellular Immunology|December 1, 1988
Characterization of interleukin 2-expanded human peripheral blood lymphocytes: not only NKH-1+-NK cells but also NKH-1+ and NKH-1- T cells are LAK effectorsH Saito, K Oshimi, Y Oshimi, et al.
Immunology|March 1, 1992
Induction of activated killer cells from human lymphocytes by medullasin (a serine protease in bone marrow cells)Y Aoki, T Hase, K Oshimi, et al.
Leukemia & Lymphoma|September 1, 1994
Interleukin-11S Kobayashi, M Teramura, K Oshimi, et al.
Pageof 21